Patents Assigned to TENEOONE, INC.
  • Anti-BCMA heavy chain-only antibodies
    Patent number: 11427642
    Abstract: Anti-BCMA heavy chain-only antibodies (UniAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: August 30, 2022
    Assignee: TENEOONE, INC.
    Inventors: Nathan Trinklein, Shelley Force Aldred, Starlynn Clarke, Wim van Schooten
  • CD3 binding antibodies
    Patent number: 11421027
    Abstract: The present invention relates to human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: August 23, 2022
    Assignee: TeneoOne, Inc.
    Inventors: Nathan Trinklein, Wim van Schooten, Shelley Force Aldred, Katherine Harris, Duy Pham
  • Multispecific heavy chain antibodies with modified heavy chain constant regions
    Patent number: 11186639
    Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: November 30, 2021
    Assignee: TENEOONE, INC.
    Inventors: Katherine Harris, Ute Schellenberger, Omid Vafa, Nathan Trinklein, Wim van Schooten, Shelley Force Aldred, Duy Pham, Starlynn Clarke